Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma

Phui Ly Liew; Chun-Sen Hsu; Wei Min Liu; Yu Chieh Lee; Yi Chih Lee; Chi Long Chen

Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma

Phui Ly Liew, Chun-Sen Hsu, Wei Min Liu, Yu Chieh Lee, Yi Chih Lee, Chi Long Chen

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: Despite considerable interest in the Nuclear factor-erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1), p16 and epithelial cadherin (E-cadherin) activation in carcinoma progression, contradictory results regarding association of Nrf2/Keap1/E-cadherin and p16 expression with clinico-pathological features and prognosis have been reported. The predictive value of these markers in ovarian carcinoma is unknown. Methods/Materials: In this retrospective study, 108 cases were evaluated immunohistochemically with antibodies to Nrf2, Keap1, estrogen receptor (ER), p16 and E-cadherin. The results were compared with histological and clinical data, disease-free survival (DFS) and overall survival (OS). Results: A cohort of 108 ovarian carcinomas (47 serous, 23 mucinous, 13 endometrioid and 25 clear cell), including 68 FIGO stage I-II cases and 40 FIGO stage III-IV cases was studied. The age of patients (P=0.005), FIGO stage (P

Original language	English
Pages (from-to)	5642-5649
Number of pages	8
Journal	International Journal of Clinical and Experimental Pathology
Volume	8
Issue number	5
Publication status	Published - 2015

Keywords

E-Cadherin
Keap1
Nrf2
Ovarian cancer
P16

ASJC Scopus subject areas

Pathology and Forensic Medicine
Histology

Access to Document

Fingerprint Dive into the research topics of 'Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma'. Together they form a unique fingerprint.

Cite this

Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. / Liew, Phui Ly; Hsu, Chun-Sen ; Liu, Wei Min; Lee, Yu Chieh; Lee, Yi Chih; Chen, Chi Long.

In: International Journal of Clinical and Experimental Pathology, Vol. 8, No. 5, 2015, p. 5642-5649.

Research output: Contribution to journal › Article › peer-review

@article{e25ade79f1a343b685d4dd7486c80cb5,

title = "Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma",

abstract = "Objectives: Despite considerable interest in the Nuclear factor-erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1), p16 and epithelial cadherin (E-cadherin) activation in carcinoma progression, contradictory results regarding association of Nrf2/Keap1/E-cadherin and p16 expression with clinico-pathological features and prognosis have been reported. The predictive value of these markers in ovarian carcinoma is unknown. Methods/Materials: In this retrospective study, 108 cases were evaluated immunohistochemically with antibodies to Nrf2, Keap1, estrogen receptor (ER), p16 and E-cadherin. The results were compared with histological and clinical data, disease-free survival (DFS) and overall survival (OS). Results: A cohort of 108 ovarian carcinomas (47 serous, 23 mucinous, 13 endometrioid and 25 clear cell), including 68 FIGO stage I-II cases and 40 FIGO stage III-IV cases was studied. The age of patients (P=0.005), FIGO stage (P",

keywords = "E-Cadherin, Keap1, Nrf2, Ovarian cancer, P16",

author = "Liew, {Phui Ly} and Chun-Sen Hsu and Liu, {Wei Min} and Lee, {Yu Chieh} and Lee, {Yi Chih} and Chen, {Chi Long}",

year = "2015",

language = "English",

volume = "8",

pages = "5642--5649",

journal = "International Journal of Clinical and Experimental Pathology",

issn = "1936-2625",

publisher = "E-CENTURY PUBLISHING CORP",

number = "5",

}

TY - JOUR

T1 - Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma

AU - Liew, Phui Ly

AU - Hsu, Chun-Sen

AU - Liu, Wei Min

AU - Lee, Yu Chieh

AU - Lee, Yi Chih

AU - Chen, Chi Long

PY - 2015

Y1 - 2015

N2 - Objectives: Despite considerable interest in the Nuclear factor-erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1), p16 and epithelial cadherin (E-cadherin) activation in carcinoma progression, contradictory results regarding association of Nrf2/Keap1/E-cadherin and p16 expression with clinico-pathological features and prognosis have been reported. The predictive value of these markers in ovarian carcinoma is unknown. Methods/Materials: In this retrospective study, 108 cases were evaluated immunohistochemically with antibodies to Nrf2, Keap1, estrogen receptor (ER), p16 and E-cadherin. The results were compared with histological and clinical data, disease-free survival (DFS) and overall survival (OS). Results: A cohort of 108 ovarian carcinomas (47 serous, 23 mucinous, 13 endometrioid and 25 clear cell), including 68 FIGO stage I-II cases and 40 FIGO stage III-IV cases was studied. The age of patients (P=0.005), FIGO stage (P

AB - Objectives: Despite considerable interest in the Nuclear factor-erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1), p16 and epithelial cadherin (E-cadherin) activation in carcinoma progression, contradictory results regarding association of Nrf2/Keap1/E-cadherin and p16 expression with clinico-pathological features and prognosis have been reported. The predictive value of these markers in ovarian carcinoma is unknown. Methods/Materials: In this retrospective study, 108 cases were evaluated immunohistochemically with antibodies to Nrf2, Keap1, estrogen receptor (ER), p16 and E-cadherin. The results were compared with histological and clinical data, disease-free survival (DFS) and overall survival (OS). Results: A cohort of 108 ovarian carcinomas (47 serous, 23 mucinous, 13 endometrioid and 25 clear cell), including 68 FIGO stage I-II cases and 40 FIGO stage III-IV cases was studied. The age of patients (P=0.005), FIGO stage (P

KW - E-Cadherin

KW - Keap1

KW - Nrf2

KW - Ovarian cancer

KW - P16

UR - http://www.scopus.com/inward/record.url?scp=84937910008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937910008&partnerID=8YFLogxK

M3 - Article

C2 - 26191276

AN - SCOPUS:84937910008

VL - 8

SP - 5642

EP - 5649

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 5

ER -